Tidal Breathing Flow-Volume (TBFV) loops in bronchiolitis in infancy: the effect of albuterol

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN47364493

Enrollment

Registered

2002-02-26

Start date

2000-01-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Syncytial Virus (RSV) bronchiolitis Respiratory Bronchiolitis

Interventions

Compared the effect of nebulized albuterol versus nebulized saline on various parameters of tidal breathing flow-volume loops

Eligibility

Inclusion criteria

Inclusion criteria: One month to one year infants with Respiratory Syncytial Virus (RSV) positive bronchiolitis

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026